We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Next-Generation Sequencing Bioinformatics Tools and Resources Developed

By Labmedica staff writers
Posted on 27 Feb 2008
A new Software Development Community supports life scientists and independent software vendors to develop and commercialize innovative bioinformatics applications for next-generation genomic analysis platforms. More...


Applied Biosystems' (Foster City, CA, USA) Software Development Community has made formal agreements with Geospiza (Seattle, WA USA) and Genome Quest (Westborough, MA, USA) to develop bioinformatics tools for analysis and management of data generated by the SOLiD system, an extremely high throughput next-generation sequencing system. The new relationships should help scientists to realize the full potential of next-generation genomic analysis.

Through its Software Development Community, Applied Biosystems is the first manufacturer of next-generation instrument systems to make software development tools and resources widely available to the bioinformatics community. As a participant in the Software Development Community, Geospiza developed a software system to automate sequencing workflows for capillary electrophoresis (CE) instrumentation, and plans to expand its relationship with Applied Biosystems to include next-generation sequencing instruments. Processing both CE and SOLiD data through a single processing pipeline will enable researchers to integrate and visualize data sets from both technologies.

GenomeQuest has an integrated sequence information system, which, based on its database of reference sequences, can convert raw sequence data from the SOLiD system into insightful information. GenomeQuest's platform should also help SOLiD system users with sequence alignment and analysis, offering increased productivity, and enabling scalability as customers increasingly use next-generation genomic analysis platforms.

Applied Biosystems is a global leader in the development and commercialization of instrument-based systems, consumables, software, and services for the life science market, and is a market leader in the commercialization of DNA sequencing platforms. The SOLiD system, based on sequencing by oligonucleotide ligation and detection, is Applied Biosystems' next-generation system for ultra-high throughput genomic analysis. The SOLiD system utilizes a proprietary technology called stepwise ligation, which generates high quality data for applications, including whole genome sequencing, chromatin immunoprecipitation (ChIP), microbial and eukaryotic resequencing, digital karyotyping, medical sequencing, genotyping, gene expression, and small RNA discovery.

Geospiza combines deep life science and information technology (IT) expertise to provide highly scalable, fully integrated regulatory compliant informatics platforms for scaling their laboratory workflow, scientific data management, and analytics workflows. The company's customers are primarily molecular diagnostic laboratories, biotechnology and pharmaceutical companies, contract core labs, large research institutes and universities, involved in clinical DNA testing, manufacturing DNA based bio-therapeutics, delivering sequencing services to outside customers and basic life science research and discovery efforts.

GenomeQuest is a genomic information company providing applications and services to manage and mine the world's sequence data. The company's flagship product, GenomeQuest, is a web-based sequence information platform that enables sequence information specialists to exploit genomic data resources including next-generation sequencing tools and worldwide biologic sequence reference databases.


Related Links:
Applied Biosystems
Geospiza
Genome Quest

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.